The Impact of AmniSure

Accurately diagnosing premature rupture of fetal membranes (PROM) is of critical importance for a clinician. An accurate diagnosis of ROM at any term during pregnancy is crucial to timely and proper treatment and to determine the need for prompt hospitalization. Failure to identify patients with ROM can result in a delay or inability to implement salutary obstetric measures. Conversely, a false positive diagnosis of ROM can lead to inappropriate or untimely interventions such as hospitalization or induction of labor.

The AmniSure ROM Test is a rapid, non-invasive immunoassay that aids clinicians with the diagnosis of ROM in pregnant women with signs and symptoms suggestive of the condition. According to published data it is ~99% accurate.

  • doctor with pregnant woman

    Diagnosing Premature Rupture of Membranes

    Over the past 75 years, more than 100 different approaches have been proposed for the diagnosis of PROM, one of the leading identifiable causes of preterm birth.

    Learn More »
  • books with stethoscope

    Cost-Effectiveness

    Timely and accurate diagnosis of ROM enables healthcare professionals to quickly determine appropriate patient care. By doing so, clinicians may avoid significant costs associated with the inaccurate results of the older methods.

    Learn More »
  • stethoscope and doctor

    Testimonials

    Nearly half of US birthing hospitals are using the AmniSure ROM Test. Hear from clinicians with firsthand experience using AmniSure in clinical practice.

    Learn More »

Questions?

Contact An AmniSure Sales Rep for Assistance